Aberrant microRNA-182 expression is associated with glucocorticoid resistance in lymphoblastic malignancies

Leukemia & Lymphoma
Apeng YangYanhui Xie

Abstract

Glucocorticoid (GC) resistance in lymphoblastic malignancies is related to treatment failure and is a marker of poor prognosis. Previous studies have suggested that microRNA-182 (miR-182) functions as an oncogene and plays a role in tumorigenesis, through regulation of FOXO3A. FOXO3A has been implicated in tumor suppression and GC-induced apoptosis, suggesting that FOXO3A has potential as a therapeutic target. Herein we investigated the role of miR-182 in GC sensitivity in lymphoblastic malignancies. Expression of miR-182 was consistently higher in human and mouse GC-resistant cell lines than in GC-sensitive cell lines. Furthermore, increased expression of miR-182 reduced total FOXO3A expression but had no significant effect on phospho-FOXO3A. Additionally Bim, as a downstream target of FOXO3A, was reduced by overexpression of miR-182, and increased by down-regulation of miR-182. These results demonstrate that miR-182 is involved in glucocorticoid resistance, via targeting of FOXO3A, and that restoration of miR-182 is a potentially promising therapeutic strategy in lymphoblastic malignancies.

References

Jan 1, 1997·Critical Reviews in Oncology/hematology·R PietersA J Veerman
Oct 27, 2001·Science·M Lagos-QuintanaT Tuschl
Jan 5, 2002·The Journal of Biological Chemistry·Tracy Tzu-Ling TangLaurence A Lasky
Aug 2, 2002·Cancer Cell·Shivapriya RamaswamyWilliam R Sellers
Oct 23, 2002·Molecular and Cellular Biology·Marc SchmidtRené H Medema
Nov 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
May 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Saghi GhaffariRoya Khosravi-Far
Jan 1, 2005·Current Opinion in Oncology·Olga Frankfurt, Steven T Rosen
Mar 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Peggy S EisJames E Dahlberg
Mar 16, 2005·Cell·Steven M JohnsonFrank J Slack
Apr 30, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Christian PlonerReinhard Kofler
Jun 10, 2005·Nature·Lin HeScott M Hammond
Jul 19, 2005·Cancer Research·Jennifer A ChanKenneth S Kosik
Oct 28, 2005·The New England Journal of Medicine·George Adrian CalinCarlo M Croce
Oct 13, 2007·Plant Methods·Erika Varkonyi-GasicRoger P Hellens
Oct 19, 2007·Nature Reviews. Cancer·Stephen S Myatt, Eric W-F Lam
Jan 22, 2008·Nature Cell Biology·Jer-Yen YangMien-Chie Hung
May 30, 2008·Haematologica·Hana BruchovaJosef T Prchal
Oct 30, 2008·Biochemical and Biophysical Research Communications·Jiexian MaYouxin Jin
Feb 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Miguel F SeguraEva Hernando
Jul 4, 2009·The Journal of Biological Chemistry·Irene K Guttilla, Bruce A White
Jul 16, 2009·Gene Expression Patterns : GEP·Rosalie SacheliBrigitte Malgrange
Mar 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Steven M KornblauKevin R Coombes
Apr 8, 2010·The Journal of Biological Chemistry·William KongJin Q Cheng
Apr 27, 2010·Pathology, Research and Practice·Iris BarshackMarina Perelman
Apr 28, 2010·Biochemical and Biophysical Research Communications·Yihua SunHaiquan Chen

❮ Previous
Next ❯

Citations

Feb 23, 2013·ISRN Hematology·Ronit Vogt Sionov
Mar 29, 2016·IEEE Transactions on Nanobioscience·Yubo YangDechang Xu
Oct 2, 2013·Nature Reviews. Endocrinology·Rogier A QuaxRichard A Feelders
Dec 31, 2016·International Journal of Oncology·Marwa Hentati-KallelAurélie Trussardi-Régnier
Mar 14, 2017·Journal of Cancer Research and Clinical Oncology·Huimin WangJuan Ouyang
Sep 26, 2015·Oncotarget·Ronit Vogt SionovZvi Granot
Mar 25, 2021·Seminars in Cancer Biology·Sara Peixoto da SilvaM Helena Vasconcelos
May 28, 2021·Frontiers in Cell and Developmental Biology·Fabian Vega-TapiaLoreto Cuitino

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis